Table 2 Description of the FeNO (ppb) according to the asthmatic status and exposure per cohort
| Â | LISA | PIAMA | INMA |
|---|---|---|---|
|  | n = 182 | n = 244 | n = 355 |
| Â | GM (Gsd) | GM (Gsd) | GM (Gsd) |
Asthma | Â | Â | |
 No | 13.7 (1.9) | 10.4 (1.9) | 11.3 (2.1) |
 Yes | 30.3 (2.3) | 13.4 (2.0) | 27.3 (3.0) |
Endotoxin concentrations (EU/mg) | Â | Â | |
 Q1 (<3.54 EU/mg) | 12.6 (1.4) | 7.8 (1.5) | 12.3 (2.4) |
 Q2 (>3.54-12.4 EU/mg) | 17.2 (1.9) | 11.5 (2.2) | 13.0 (2.2) |
 Q3 (>12.4-30.6 EU/mg) | 14.3 (2.0) | 10.1 (1.9) | 11.8 (2.1) |
 Q4 (>30.6 EU/mg) | 14.4 (2.0) | 9.7 (1.8) | 11.5 (2.2) |
EPS concentrations (U/mg) | Â | Â | |
 <LOD | 14.2 (2.3) | 9.5 (2.0) | 10.4 (1.8) |
 T1 (<42 U/mg) | 15.2 (2.0) | 10.6 (2.0) | 11.8 (2.3) |
 T2 (>42-101 U/mg) | 13.8 (1.9) | 9.9 (1.9) | 12.1 (2.1) |
 T3 (>101 U/mg) | 16.2 (2.2) | 12.5 (1.8) | 13.2 (2.4) |
Glucan concentrations (ug/mg) | Â | Â | |
 <LOD | - | 9.4 (2.1) | - |
 T1 (<1.55 μg/mg) | 15.8 (2.0) | 10.9 (1.9) | - |
 T2 (>1.55-2.35 μg/mg) | 13.6 (1.9) | 10.3 (1.9) | - |
 T3 (>2.35 μg/mg) | 15.4 (2.1) | 10.7 (1.8) | - |
Dampness at home | Â | Â | |
 Never | 14.9 (2.0) | 10.7 (1.9) | 12.9 (2.3) |
 Ever during the first 2 years of life | 14.3 (2.1) | 10.0 (2.0) | 12.1 (2.3) |
Cat ownership | Â | Â | |
 Never | 15.5 (2.0) | 10.6 (1.9) | 12.7 (2.3) |
 Ever during the first 2 years of life | 16.1 (2.1) | 9.7 (1.8) | 10.8 (2.2) |
 Ever after the first 2 years of life | 11.4 (1.7) | 9.9 (2.4) | 15.1 (2.5) |
Dog ownership | Â | Â | |
 Never | 15.1 (2.0) | 10.5 (2.0) | 13.3 (2.4) |
 Ever during the first 2 years of life | 13.4 (1.6) | 9.0 (1.8) | 11.6 (2.3) |
 Ever after the first 2 years of life | 15.5 (1.6) | 10.9 (2.1) | 12.3 (2.1) |